Their findings suggested that EPLIN overexpression was particularly pronounced in HPV-negative HNSCC cases with TP53 mutations, indicating its potential role as an oncogene in HNSCC progression and its possible utility as a biomarker for this specific subtype. The gene discussed is LIMA1; the disease is head and neck squamous cell carcinoma.